IN2012DN06392A - - Google Patents

Info

Publication number
IN2012DN06392A
IN2012DN06392A IN6392DEN2012A IN2012DN06392A IN 2012DN06392 A IN2012DN06392 A IN 2012DN06392A IN 6392DEN2012 A IN6392DEN2012 A IN 6392DEN2012A IN 2012DN06392 A IN2012DN06392 A IN 2012DN06392A
Authority
IN
India
Prior art keywords
blood group
group phenotype
secretor blood
found
intestine
Prior art date
Application number
Other languages
English (en)
Inventor
Pirjo Wacklin
Jaana Mättö
Harri Mäkivuokko
Original Assignee
Suomen Punainen Risti Veripalvelu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalvelu filed Critical Suomen Punainen Risti Veripalvelu
Publication of IN2012DN06392A publication Critical patent/IN2012DN06392A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN6392DEN2012 2009-12-28 2010-12-28 IN2012DN06392A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20096402A FI20096402A0 (fi) 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö II
US12/843,405 US20110158951A1 (en) 2009-12-28 2010-07-26 Use of blood group status ii
PCT/FI2010/051094 WO2011080396A2 (en) 2009-12-28 2010-12-28 Use of blood group status ii

Publications (1)

Publication Number Publication Date
IN2012DN06392A true IN2012DN06392A (enExample) 2015-10-02

Family

ID=41462860

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6392DEN2012 IN2012DN06392A (enExample) 2009-12-28 2010-12-28

Country Status (7)

Country Link
US (1) US20110158951A1 (enExample)
EP (1) EP2519256A2 (enExample)
CN (1) CN102770154B (enExample)
BR (1) BR112012016910A2 (enExample)
FI (1) FI20096402A0 (enExample)
IN (1) IN2012DN06392A (enExample)
WO (1) WO2011080396A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012013861A2 (en) * 2010-07-26 2012-02-02 Suomen Punainen Risti Veripalvelu Use of blood group status iii
FI20105824A0 (fi) * 2010-07-26 2010-07-26 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö IV
WO2015071389A1 (en) 2013-11-15 2015-05-21 Nestec S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
HK1251250A1 (zh) * 2015-06-30 2019-01-25 完美（中国）有限公司 作为肠道菌群的益生基础菌种的双歧杆菌
CN105105115A (zh) * 2015-08-21 2015-12-02 暨南大学 针对abo血型人群的益生菌复合物及其方法与应用
CN113718047B (zh) * 2021-11-04 2022-02-18 艾德范思(北京)医学检验实验室有限公司 荧光定量方法检测人母乳内10属细菌的试剂盒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826928A1 (de) * 1998-06-17 1999-12-23 Novartis Consumer Health Gmbh Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
US6436451B1 (en) * 1999-03-26 2002-08-20 Eggland's Best, Inc. Method of reducing cholesterol in chicken eggs
US6613549B2 (en) * 2000-02-10 2003-09-02 Urex Biotech, Inc. Probiotic therapy for newborns
JP4709838B2 (ja) * 2004-08-05 2011-06-29 アニドラル エス．アール．エル． 葉酸産生ビフィドバクテリウム菌株、製剤およびこれらの用途
WO2009033011A1 (en) * 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease

Also Published As

Publication number Publication date
WO2011080396A2 (en) 2011-07-07
FI20096402A0 (fi) 2009-12-28
EP2519256A2 (en) 2012-11-07
CN102770154B (zh) 2015-12-02
CN102770154A (zh) 2012-11-07
BR112012016910A2 (pt) 2018-05-29
US20110158951A1 (en) 2011-06-30
WO2011080396A3 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
IN2012DN06392A (enExample)
IN2012DN01638A (enExample)
GB2480042A (en) Prebiotic formulations and methods of use
WO2012013861A3 (en) Use of blood group status iii
AU2016204346A1 (en) Methods and compositions for cell-proliferation-related disorders
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
PH12015501470A1 (en) Compositions and methods for the control of nematodes and soil borne diseases
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
BR112012033212A2 (pt) uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica
AU331248S (en) Symmetrical dental bilateral bite block
PL2513023T3 (pl) Kompozycje i zastosowania cis-1,1,1,4,4,4-heksafluoro-2-butenu
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
MX367109B (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
ZA200908063B (en) Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
AR071330A1 (es) Cepa de lactobacillus paracasei subsp paracasei dotada de propiedades antimicrobianas e inmunomoduladoras
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
FI20116007A0 (fi) Serotoniinitason nostaminen ja diagnostisointi
MX2010008137A (es) Bacterias no patogenas y/o atenuadas capaces de inducir apoptosis en macrofagos, proceso de fabricacion y su usos.
FI20105825A0 (fi) Veriryhmästatuksen käyttö III
MY152437A (en) Oral care compositions
MX346332B (es) Cepas probioticas para aumentar la resistencia transepitelial.
MY158310A (en) Prevention and treatment of allergic diarrhoea
PH12015501099A1 (en) Synbiotic composition and use thereof
IN2012DN06393A (enExample)
WO2007084861A3 (en) Xenohormesis based compositions and methods